Table II. Glycopeptides identified in this study.
| site | # | Peptide | Mo02 (V/V) | MoA (V/F) | MoB (V/F) | Mo11 (V/F) | Mo13 (F/F) | Mo15 (V/F) | glycopeptide glycoforms |
|---|---|---|---|---|---|---|---|---|---|
| N38 | 1 | KCQGAYSPEDNSTQW | 6 | 2 | 5 | 7 | n.d. | 2 | 11 |
| 2 | SPEDNSTQW | 3 | 3 | n.d. | 7 | n.d. | n.d. | 9 | |
| N45 | 1 | FHNE | 17 | 16 | 10 | 14 | 11 | 15 | 21 |
| 2 | FHNESLISSQASSY | 5 | 18 | 18 | 8 | 3 | 10 | 28 | |
| N74 | 1 | RCQTNLSTLSDPVQLE | 16 | 7 | 5 | 3 | 4 | 3 | 24 |
| N162 (V158) | 1 | CRGLVGSKNVSSE | 10 | 20 | 8 | 15 | n.a. | 6 | 21 |
| N162 (F158) | 2 | GSKNVSSE | n.a. | 1 | 6 | 2 | 2 | 4 | 6 |
| N169 | 1 | TVNITITQGL | 5 | 7 | 3 | 2 | 2 | 2 | 9 |
| 2 | TVNITITQGLA | n.d. | 1 | 2 | 3 | 2 | n.d. | 4 | |
| # of total glycan compositions: | 77 | ||||||||
n.a. = not applicable; n.d. = not detected.